dipotassium;6-bromo-4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazine;6-bromo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine;1-(bromomethyl)-4-chloro-2-fluorobenzene;tert-butyl 4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazine-1-carboxylate;tert-butyl 2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;tert-butyl 2-(chloromethyl)-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylic acid;4-[(4-chloro-2-fluorophenyl)methyl]-6-piperazin-1-yl-2,3-dihydropyrido[3,2-b][1,4]oxazine;fluoromethyl deuteriomethaneperoxoate

C157H166Br3Cl7F7K2N32O17+ — CID 159549075

About dipotassium;6-bromo-4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazine;6-bromo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine;1-(bromomethyl)-4-chloro-2-fluorobenzene;tert-butyl 4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazine-1-carboxylate;tert-butyl 2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;tert-butyl 2-(chloromethyl)-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylic acid;4-[(4-chloro-2-fluorophenyl)methyl]-6-piperazin-1-yl-2,3-dihydropyrido[3,2-b][1,4]oxazine;fluoromethyl deuteriomethaneperoxoate

dipotassium;6-bromo-4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazine;6-bromo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine;1-(bromomethyl)-4-chloro-2-fluorobenzene;tert-butyl 4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazine-1-carboxylate;tert-butyl 2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;tert-butyl 2-(chloromethyl)-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylic acid;4-[(4-chloro-2-fluorophenyl)methyl]-6-piperazin-1-yl-2,3-dihydropyrido[3,2-b][1,4]oxazine;fluoromethyl deuteriomethaneperoxoate (PubChem CID 159549075) has the molecular formula C157H166Br3Cl7F7K2N32O17+ and a molecular weight of 3473.33 g/mol. Its IUPAC name is dipotassium;6-bromo-4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazine;6-bromo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine;1-(bromomethyl)-4-chloro-2-fluorobenzene;tert-butyl 4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazine-1-carboxylate;tert-butyl 2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;tert-butyl 2-(chloromethyl)-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylic acid;4-[(4-chloro-2-fluorophenyl)methyl]-6-piperazin-1-yl-2,3-dihydropyrido[3,2-b][1,4]oxazine;fluoromethyl deuteriomethaneperoxoate.

Molecular Properties

• Compound Name: dipotassium;6-bromo-4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazine;6-bromo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine;1-(bromomethyl)-4-chloro-2-fluorobenzene;tert-butyl 4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazine-1-carboxylate;tert-butyl 2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;tert-butyl 2-(chloromethyl)-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylic acid;4-[(4-chloro-2-fluorophenyl)methyl]-6-piperazin-1-yl-2,3-dihydropyrido[3,2-b][1,4]oxazine;fluoromethyl deuteriomethaneperoxoate
• PubChem CID: 159549075
• Molecular Formula: C157H166Br3Cl7F7K2N32O17+
• Molecular Weight: 3473.33 g/mol
• Exact Mass: 3464.77
• IUPAC Name: dipotassium;6-bromo-4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazine;6-bromo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine;1-(bromomethyl)-4-chloro-2-fluorobenzene;tert-butyl 4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazine-1-carboxylate;tert-butyl 2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;tert-butyl 2-(chloromethyl)-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylic acid;4-[(4-chloro-2-fluorophenyl)methyl]-6-piperazin-1-yl-2,3-dihydropyrido[3,2-b][1,4]oxazine;fluoromethyl deuteriomethaneperoxoate
• SMILES: Brc1ccc2c(n1)NCCO2.CC(C)(C)OC(=O)N1CCN(c2ccc3c(n2)N(Cc2ccc(Cl)cc2F)CCO3)CC1.Cn1ccnc1Cn1c(CCl)nc2ccc(C(=O)OC(C)(C)C)cc21.Cn1ccnc1Cn1c(CN2CCN(c3ccc4c(n3)N(Cc3ccc(Cl)cc3F)CCO4)CC2)nc2ccc(C(=O)O)cc21.Cn1ccnc1Cn1c(CN2CCN(c3ccc4c(n3)N(Cc3ccc(Cl)cc3F)CCO4)CC2)nc2ccc(C(=O)OC(C)(C)C)cc21.Fc1cc(Cl)ccc1CBr.Fc1cc(Cl)ccc1CN1CCOc2ccc(Br)nc21.Fc1cc(Cl)ccc1CN1CCOc2ccc(N3CCNCC3)nc21.[2H]C(=O)OO[CH-]F.[K+].[K+]
• InChI: InChI=1S/C36H40ClFN8O3.C32H32ClFN8O3.C23H28ClFN4O3.C18H20ClFN4O.C18H21ClN4O2.C14H11BrClFN2O.C7H5BrClF.C7H7BrN2O.C2H2FO3.2K/c1-36(2,3)49-35(47)24-6-8-28-29(19-24)46(23-32-39-11-12-42(32)4)33(40-28)22-43-13-15-44(16-14-43)31-10-9-30-34(41-31)45(17-18-48-30)21-25-5-7-26(37)20-27(25)38;1-38-9-8-35-29(38)20-42-26-16-21(32(43)44)3-5-25(26)36-30(42)19-39-10-12-40(13-11-39)28-7-6-27-31(37-28)41(14-15-45-27)18-22-2-4-23(33)17-24(22)34;1-23(2,3)32-22(30)28-10-8-27(9-11-28)20-7-6-19-21(26-20)29(12-13-31-19)15-16-4-5-17(24)14-18(16)25;19-14-2-1-13(15(20)11-14)12-24-9-10-25-16-3-4-17(22-18(16)24)23-7-5-21-6-8-23;1-18(2,3)25-17(24)12-5-6-13-14(9-12)23(15(10-19)21-13)11-16-20-7-8-22(16)4;15-13-4-3-12-14(18-13)19(5-6-20-12)8-9-1-2-10(16)7-11(9)17;8-4-5-1-2-6(9)3-7(5)10;8-6-2-1-5-7(10-6)9-3-4-11-5;3-1-5-6-2-4;;/h5-12,19-20H,13-18,21-23H2,1-4H3;2-9,16-17H,10-15,18-20H2,1H3,(H,43,44);4-7,14H,8-13,15H2,1-3H3;1-4,11,21H,5-10,12H2;5-9H,10-11H2,1-4H3;1-4,7H,5-6,8H2;1-3H,4H2;1-2H,3-4H2,(H,9,10);1-2H;;/q;;;;;;;;-1;2*+1/i;;;;;;;;2D
• InChIKey: TZWSOFSDYVSUGQ-VEZMNMDYSA-N
• XLogP: 23.88
• TPSA: 454.31 Ų
• H-Bond Donors: 3
• H-Bond Acceptors: 47
• Rotatable Bonds: 31
• Heavy Atoms: 225
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	3473.33
LogP ≤ 5	23.88
H-Bond Donors ≤ 5	3
H-Bond Acceptors ≤ 10	47

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of dipotassium;6-bromo-4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazine;6-bromo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine;1-(bromomethyl)-4-chloro-2-fluorobenzene;tert-butyl 4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazine-1-carboxylate;tert-butyl 2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;tert-butyl 2-(chloromethyl)-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylic acid;4-[(4-chloro-2-fluorophenyl)methyl]-6-piperazin-1-yl-2,3-dihydropyrido[3,2-b][1,4]oxazine;fluoromethyl deuteriomethaneperoxoate?

The IUPAC name of dipotassium;6-bromo-4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazine;6-bromo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine;1-(bromomethyl)-4-chloro-2-fluorobenzene;tert-butyl 4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazine-1-carboxylate;tert-butyl 2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;tert-butyl 2-(chloromethyl)-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylic acid;4-[(4-chloro-2-fluorophenyl)methyl]-6-piperazin-1-yl-2,3-dihydropyrido[3,2-b][1,4]oxazine;fluoromethyl deuteriomethaneperoxoate (CID 159549075) is dipotassium;6-bromo-4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazine;6-bromo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine;1-(bromomethyl)-4-chloro-2-fluorobenzene;tert-butyl 4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazine-1-carboxylate;tert-butyl 2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;tert-butyl 2-(chloromethyl)-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylic acid;4-[(4-chloro-2-fluorophenyl)methyl]-6-piperazin-1-yl-2,3-dihydropyrido[3,2-b][1,4]oxazine;fluoromethyl deuteriomethaneperoxoate.

What is the SMILES notation for dipotassium;6-bromo-4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazine;6-bromo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine;1-(bromomethyl)-4-chloro-2-fluorobenzene;tert-butyl 4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazine-1-carboxylate;tert-butyl 2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;tert-butyl 2-(chloromethyl)-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylic acid;4-[(4-chloro-2-fluorophenyl)methyl]-6-piperazin-1-yl-2,3-dihydropyrido[3,2-b][1,4]oxazine;fluoromethyl deuteriomethaneperoxoate?

The canonical SMILES for dipotassium;6-bromo-4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazine;6-bromo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine;1-(bromomethyl)-4-chloro-2-fluorobenzene;tert-butyl 4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazine-1-carboxylate;tert-butyl 2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;tert-butyl 2-(chloromethyl)-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylic acid;4-[(4-chloro-2-fluorophenyl)methyl]-6-piperazin-1-yl-2,3-dihydropyrido[3,2-b][1,4]oxazine;fluoromethyl deuteriomethaneperoxoate is Brc1ccc2c(n1)NCCO2.CC(C)(C)OC(=O)N1CCN(c2ccc3c(n2)N(Cc2ccc(Cl)cc2F)CCO3)CC1.Cn1ccnc1Cn1c(CCl)nc2ccc(C(=O)OC(C)(C)C)cc21.Cn1ccnc1Cn1c(CN2CCN(c3ccc4c(n3)N(Cc3ccc(Cl)cc3F)CCO4)CC2)nc2ccc(C(=O)O)cc21.Cn1ccnc1Cn1c(CN2CCN(c3ccc4c(n3)N(Cc3ccc(Cl)cc3F)CCO4)CC2)nc2ccc(C(=O)OC(C)(C)C)cc21.Fc1cc(Cl)ccc1CBr.Fc1cc(Cl)ccc1CN1CCOc2ccc(Br)nc21.Fc1cc(Cl)ccc1CN1CCOc2ccc(N3CCNCC3)nc21.[2H]C(=O)OO[CH-]F.[K+].[K+].

What is the InChIKey of dipotassium;6-bromo-4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazine;6-bromo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine;1-(bromomethyl)-4-chloro-2-fluorobenzene;tert-butyl 4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazine-1-carboxylate;tert-butyl 2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;tert-butyl 2-(chloromethyl)-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylic acid;4-[(4-chloro-2-fluorophenyl)methyl]-6-piperazin-1-yl-2,3-dihydropyrido[3,2-b][1,4]oxazine;fluoromethyl deuteriomethaneperoxoate?

The InChIKey is TZWSOFSDYVSUGQ-VEZMNMDYSA-N. The full InChI is InChI=1S/C36H40ClFN8O3.C32H32ClFN8O3.C23H28ClFN4O3.C18H20ClFN4O.C18H21ClN4O2.C14H11BrClFN2O.C7H5BrClF.C7H7BrN2O.C2H2FO3.2K/c1-36(2,3)49-35(47)24-6-8-28-29(19-24)46(23-32-39-11-12-42(32)4)33(40-28)22-43-13-15-44(16-14-43)31-10-9-30-34(41-31)45(17-18-48-30)21-25-5-7-26(37)20-27(25)38;1-38-9-8-35-29(38)20-42-26-16-21(32(43)44)3-5-25(26)36-30(42)19-39-10-12-40(13-11-39)28-7-6-27-31(37-28)41(14-15-45-27)18-22-2-4-23(33)17-24(22)34;1-23(2,3)32-22(30)28-10-8-27(9-11-28)20-7-6-19-21(26-20)29(12-13-31-19)15-16-4-5-17(24)14-18(16)25;19-14-2-1-13(15(20)11-14)12-24-9-10-25-16-3-4-17(22-18(16)24)23-7-5-21-6-8-23;1-18(2,3)25-17(24)12-5-6-13-14(9-12)23(15(10-19)21-13)11-16-20-7-8-22(16)4;15-13-4-3-12-14(18-13)19(5-6-20-12)8-9-1-2-10(16)7-11(9)17;8-4-5-1-2-6(9)3-7(5)10;8-6-2-1-5-7(10-6)9-3-4-11-5;3-1-5-6-2-4;;/h5-12,19-20H,13-18,21-23H2,1-4H3;2-9,16-17H,10-15,18-20H2,1H3,(H,43,44);4-7,14H,8-13,15H2,1-3H3;1-4,11,21H,5-10,12H2;5-9H,10-11H2,1-4H3;1-4,7H,5-6,8H2;1-3H,4H2;1-2H,3-4H2,(H,9,10);1-2H;;/q;;;;;;;;-1;2*+1/i;;;;;;;;2D;;.

What are the key properties of dipotassium;6-bromo-4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazine;6-bromo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine;1-(bromomethyl)-4-chloro-2-fluorobenzene;tert-butyl 4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazine-1-carboxylate;tert-butyl 2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;tert-butyl 2-(chloromethyl)-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylic acid;4-[(4-chloro-2-fluorophenyl)methyl]-6-piperazin-1-yl-2,3-dihydropyrido[3,2-b][1,4]oxazine;fluoromethyl deuteriomethaneperoxoate?

dipotassium;6-bromo-4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazine;6-bromo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine;1-(bromomethyl)-4-chloro-2-fluorobenzene;tert-butyl 4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazine-1-carboxylate;tert-butyl 2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;tert-butyl 2-(chloromethyl)-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylic acid;4-[(4-chloro-2-fluorophenyl)methyl]-6-piperazin-1-yl-2,3-dihydropyrido[3,2-b][1,4]oxazine;fluoromethyl deuteriomethaneperoxoate has a molecular weight of 3473.33 g/mol, XLogP of 23.88, 31 rotatable bonds, 3 hydrogen bond donors, and 47 hydrogen bond acceptors.

Where does this data come from?

All data for dipotassium;6-bromo-4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazine;6-bromo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine;1-(bromomethyl)-4-chloro-2-fluorobenzene;tert-butyl 4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazine-1-carboxylate;tert-butyl 2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;tert-butyl 2-(chloromethyl)-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylate;2-[[4-[4-[(4-chloro-2-fluorophenyl)methyl]-2,3-dihydropyrido[3,2-b][1,4]oxazin-6-yl]piperazin-1-yl]methyl]-3-[(1-methylimidazol-2-yl)methyl]benzimidazole-5-carboxylic acid;4-[(4-chloro-2-fluorophenyl)methyl]-6-piperazin-1-yl-2,3-dihydropyrido[3,2-b][1,4]oxazine;fluoromethyl deuteriomethaneperoxoate is sourced from PubChem (CID 159549075), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).